Skip to main content
Top
Published in: Acta Diabetologica 6/2013

01-12-2013 | Original Article

Optimal HbA1c cutoff for detecting diabetic retinopathy

Authors: Nam H. Cho, Tae Hyuk Kim, Se Joon Woo, Kyu Hyung Park, Soo Lim, Young Min Cho, Kyong Soo Park, Hak C. Jang, Sung Hee Choi

Published in: Acta Diabetologica | Issue 6/2013

Login to get access

Abstract

The associations between high glucose levels and diabetic retinopathy have been the basis for the diagnosis of diabetes. We aimed to provide updated data on the relationship between HbA1c and diabetic retinopathy, and to assess the diagnostic accuracy of the proposed HbA1c cutoff for detecting diabetic retinopathy. This cross-sectional study included 3,403 adults from the 2009 to 2010 Ansung Cohort Study. Retinopathy was assessed with single-field nonmydriatic fundus photography and graded according to the International Clinical Diabetic Retinopathy Disease Severity Scale. HbA1c was measured by standardized assay using high performance liquid chromatography. Based on deciles distribution, the prevalence of retinopathy was very low until the HbA1c range of 48–51 mmol/mol (6.5–6.8 %). The optimal HbA1c cutoff for detecting any diabetic retinopathy was 49 mmol/mol (6.6 %), moderate or severer retinopathy was 52 mmol/mol (6.9 %) from receiver operating characteristic curve analysis. The proposed HbA1c threshold of 48 mmol/mol (6.5 %) from American Diabetes Association produced comparable accuracy for identifying both any and moderate/severer retinopathy. This study confirmed that the proposed HbA1c threshold of 48 mmol/mol (6.5 %) allowed the proper detection of diabetic retinopathy. Our data support the judicious use of HbA1c for the diagnosis of diabetes and detecting diabetic retinopathy as well.
Literature
1.
go back to reference Selvin E, Steffes MW, Zhu H et al (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800–811PubMedCrossRef Selvin E, Steffes MW, Zhu H et al (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800–811PubMedCrossRef
2.
go back to reference Bonora E, Tuomilehto J (2011) The pros and cons of diagnosing diabetes with A1C. Diabetes Care 34(Suppl 2):S184–190PubMedCrossRef Bonora E, Tuomilehto J (2011) The pros and cons of diagnosing diabetes with A1C. Diabetes Care 34(Suppl 2):S184–190PubMedCrossRef
3.
go back to reference American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–69CrossRef American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–69CrossRef
4.
go back to reference Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
5.
go back to reference Kramer CK, Rodrigues TC, Canani LH et al (2011) Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care 34:1238–1244PubMedCrossRef Kramer CK, Rodrigues TC, Canani LH et al (2011) Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care 34:1238–1244PubMedCrossRef
6.
go back to reference Karlberg C, Falk C, Green A et al (2012) Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients. Acta Diabetol 49:263–268PubMedCrossRef Karlberg C, Falk C, Green A et al (2012) Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients. Acta Diabetol 49:263–268PubMedCrossRef
7.
go back to reference Mohamed Q, Gillies MC, Wong TY (2007) Management of diabetic retinopathy: a systematic review. JAMA 298:902–916PubMedCrossRef Mohamed Q, Gillies MC, Wong TY (2007) Management of diabetic retinopathy: a systematic review. JAMA 298:902–916PubMedCrossRef
8.
go back to reference Choi SH, Kim TH, Lim S et al (2011) Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 34:944–949PubMedCrossRef Choi SH, Kim TH, Lim S et al (2011) Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 34:944–949PubMedCrossRef
9.
go back to reference STAT-Korea (2003) Census. Daejeon, Korea, Korea National Statistical Office STAT-Korea (2003) Census. Daejeon, Korea, Korea National Statistical Office
10.
go back to reference Hanas R, John G, International HBA1c Concensus Committee (2010) 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 33:1903–1904PubMedCrossRef Hanas R, John G, International HBA1c Concensus Committee (2010) 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 33:1903–1904PubMedCrossRef
11.
go back to reference Lin DY, Blumenkranz MS, Brothers RJ et al (2002) The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134:204–213PubMedCrossRef Lin DY, Blumenkranz MS, Brothers RJ et al (2002) The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134:204–213PubMedCrossRef
13.
go back to reference Colagiuri S, Lee CM, Wong TY et al (2011) Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 34:145–150PubMedCrossRef Colagiuri S, Lee CM, Wong TY et al (2011) Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 34:145–150PubMedCrossRef
14.
go back to reference Stratton IM, Kohner EM, Aldington SJ et al (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44:156–163PubMedCrossRef Stratton IM, Kohner EM, Aldington SJ et al (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44:156–163PubMedCrossRef
15.
go back to reference Yu T, Mitchell P, Berry G et al (1998) Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 116:83–89PubMedCrossRef Yu T, Mitchell P, Berry G et al (1998) Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 116:83–89PubMedCrossRef
16.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845PubMedCrossRef DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845PubMedCrossRef
17.
go back to reference Sabanayagam C, Liew G, Tai ES et al (2009) Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 52:1279–1289PubMedCrossRef Sabanayagam C, Liew G, Tai ES et al (2009) Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 52:1279–1289PubMedCrossRef
18.
go back to reference Massin P, Lange C, Tichet J et al (2011) Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol 129:188–195PubMedCrossRef Massin P, Lange C, Tichet J et al (2011) Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol 129:188–195PubMedCrossRef
19.
go back to reference Malkani S, Mordes JP (2011) Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med 124:395–401PubMedCrossRef Malkani S, Mordes JP (2011) Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med 124:395–401PubMedCrossRef
20.
go back to reference McCance DR, Hanson RL, Charles MA et al (1994) Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323–1328PubMedCrossRef McCance DR, Hanson RL, Charles MA et al (1994) Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323–1328PubMedCrossRef
21.
go back to reference Engelgau MM, Thompson TJ, Herman WH et al (1997) Comparison of fasting and 2-h glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 20:785–791PubMedCrossRef Engelgau MM, Thompson TJ, Herman WH et al (1997) Comparison of fasting and 2-h glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 20:785–791PubMedCrossRef
22.
go back to reference International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef
23.
go back to reference Cowie CC, Rust KF, Byrd-Holt DD et al (2010) Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 33:562–568PubMedCrossRef Cowie CC, Rust KF, Byrd-Holt DD et al (2010) Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 33:562–568PubMedCrossRef
24.
go back to reference Kowall B, Rathmann W, Landgraf R (2011) Is HbA1c a valid and feasible tool for the diagnosis of diabetes? Diabetes Res Clin Pract 93:314–316PubMedCrossRef Kowall B, Rathmann W, Landgraf R (2011) Is HbA1c a valid and feasible tool for the diagnosis of diabetes? Diabetes Res Clin Pract 93:314–316PubMedCrossRef
25.
go back to reference Mannucci E, Monami M, Lamanna C et al (2012) Post-prandial glucose and diabetic complications: systematic review of observational studies. Acta Diabetol 49:307–314PubMedCrossRef Mannucci E, Monami M, Lamanna C et al (2012) Post-prandial glucose and diabetic complications: systematic review of observational studies. Acta Diabetol 49:307–314PubMedCrossRef
26.
go back to reference van Leiden HA, Moll AC, Dekker JM et al (2003) Photography or ophthalmoscopy for detection of diabetic retinopathy? Diabetes Care 26:1318–1319PubMedCrossRef van Leiden HA, Moll AC, Dekker JM et al (2003) Photography or ophthalmoscopy for detection of diabetic retinopathy? Diabetes Care 26:1318–1319PubMedCrossRef
27.
go back to reference Vujosevic S, Benetti E, Massignan F et al (2009) Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol 148:111–118PubMedCrossRef Vujosevic S, Benetti E, Massignan F et al (2009) Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol 148:111–118PubMedCrossRef
28.
go back to reference Williams GA, Scott IU, Haller JA et al (2004) Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 111:1055–1062PubMedCrossRef Williams GA, Scott IU, Haller JA et al (2004) Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 111:1055–1062PubMedCrossRef
Metadata
Title
Optimal HbA1c cutoff for detecting diabetic retinopathy
Authors
Nam H. Cho
Tae Hyuk Kim
Se Joon Woo
Kyu Hyung Park
Soo Lim
Young Min Cho
Kyong Soo Park
Hak C. Jang
Sung Hee Choi
Publication date
01-12-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 6/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0452-3

Other articles of this Issue 6/2013

Acta Diabetologica 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.